Form D · Pharmaceuticals

Romark Global Pharma, LLC

Guaynabo, PR · CIK 0001666694

Offering snapshot reported Mar 8, 2017 · SEC filing

Reported sold
$13.8M
Offering amount: $50M
Investors reported
40
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Oct 9, 2015
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$6.92M$13.8MFeb 24, 2016: $10,710,000.00Feb 24, 2016Mar 15, 2016: $10,710,000.00Mar 8, 2017: $13,835,000.00Mar 8, 2017

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$10,710,000 → $13,835,000
  • Reported investors26 → 40

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 8, 2017Amendment$13,835,000$3,125,000vs Mar 15, 201640SEC filing
Mar 15, 2016Amendment$10,710,000$0vs Feb 24, 201626SEC filing
Feb 24, 2016Initial$10,710,000No comparison26SEC filing

Offering details

Securities
Debt, Other
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$1.5M (estimated)
Finders' fees
$0
Form D file number
021-258025
Convertible into Romark SCS Common Units
Commissions paid will be based on 3% of the gross proceeds raised in the offering through the services of the placement agent.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Francisco Jose Rivera2303039Pariter Securities, LLC · CRD 127836

Source: Form D, filed Mar 8, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Marc S. Ayers Director, Executive, Promoter
Wayne Burks Executive
W. Seymour Holt Director
W. Andrew Krusen Jr. Director
Celine Rossignol Executive
Jean Francois Rossignol, M.D., Ph.D. Director, Executive, Promoter
Brian Schnieders Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
B5 Tabonuco Street, Suite #216, Pmt 317
Guaynabo, PR, 00968